-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Elevance Health, Raises Price Target to $475

Benzinga·07/14/2026 13:31:07
语音播报
Truist Securities analyst David Macdonald maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $450 to $475.